Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom and internationally. The company's binders engineered
to address issues which founds with molecules, such as antibodies; and offers solutions to bioprocessing, diagnostic, and pharmaceutical scientists. It serves pharma companies, diagnostic development companies, and research institutes. The company was incorporated in 2014 and is based in York, the United Kingdom. The company trades on AIM exchange marketplace. The company headquarter is located in York, United Kingdom. The company was established in the 2021. The company's ISIN is GB00BNRRP542.
| Ticker | APTA |
| Long Name | Aptamer Group plc |
| Short Name | Aptamer Group PLC |
| Sector | Healthcare |
| Subsector | Biotechnology |
| Subsector 2 | |
| Currency | GBX |
| ISIN | GB00BNRRP542 |